Curated News
By: NewsRamp Editorial Staff
May 16, 2025
Bionoid Pharma Rebrands as AI Maverick Intel, Inc. to Focus on AI-Powered Customer Acquisition Solutions
TLDR
- Bionoid Pharma rebrands as AI Maverick Intel, Inc., enhancing AI-powered customer acquisition solutions for competitive advantage.
- AI Maverick Intel, Inc. offers AI-based audience automation and two-way communication for targeted engagement in healthcare and biotech sectors.
- AI Maverick Intel, Inc. aims to improve operational efficiency and engagement across sectors, contributing to a better future through AI technology.
- Bionoid Pharma's transformation into AI Maverick Intel, Inc. highlights innovative AI solutions, paving the way for dynamic communication systems.
Impact - Why it Matters
This news matters as it highlights a strategic shift towards AI technology in customer acquisition and engagement. The transformation of Bionoid Pharma to AI Maverick Intel, Inc. signifies a move towards innovative solutions that could impact various industries, including healthcare and biotech.
Summary
Bionoid Pharma (OTC PINK: BINP) has rebranded as AI Maverick Intel, Inc., focusing on AI-powered customer acquisition solutions through the acquisition of AI Maverick Intel. The company plans to deploy its technology in healthcare and biotech sectors for enhanced targeting and engagement.
Source Statement
This curated news summary relied on content disributed by InvestorBrandNetwork (IBN). Read the original source here, Bionoid Pharma Rebrands as AI Maverick Intel, Inc. to Focus on AI-Powered Customer Acquisition Solutions
